Recommended
More Related Content
What's hot
What's hot (20)
Viewers also liked
Viewers also liked (20)
Similar to Perpective Management- Pharmaceutical Industry Overview
Similar to Perpective Management- Pharmaceutical Industry Overview (20)
More from sdusane1
Recently uploaded
Recently uploaded (17)
Perpective Management- Pharmaceutical Industry Overview
- 1. Sagar Dusane MMS- B-11-(2015-17) AIAIMS- Mumbai 01 Perspective Management
- 2. History • Sushruta Samhita, an Indian Ayurvedic treatise 6th century BC • Ancient Egyptian papyri such as the Ebers Papyrus of 1550 BC. • Ancient Greece, Diocles of Carystus (4th century BC) medicinal properties of plants • Galen is the father of pharmacy • Prof. William Procter, father of American pharmacy
- 3. GlaxoSmithKline plc (GSK) • Founded 2000; 15 years ago • Headquarters- Brentford, London, United Kingdom • Products- Pharmaceuticals, vaccines, oral healthcare products, nutritional products, over-the-counter medicines. • Number of employees - 96,575 (2015) • Slogan- "Do more, feel better, live longer"
- 4. Pfizer, Inc. • Founded 1849; 166 years ago • Headquarters New York City, New York, United States • Number of employees- 78,000 (2014) • Slogan- Doing things differently
- 5. Products of GSK The GSK India product portfolio includes prescription medicines and vaccines. GSK prescription medicines range across therapeutic areas and GSK also offer a range of vaccines.
- 6. Category of Drugs • Antibiotic drugs • Analgesic drugs • Anticancer drugs • Vaccines • Derma products
- 7. Antibiotics • Augmentin DDS • Augmentin (I.V.) • Augmentin tabs • Cetzin A
- 9. VACCINES •Engerix-B : Hepatitis B Vaccine •Havrix : Inactivated Hepatitis A virus Vaccine
- 10. Products of Pfizer Pfizer products reflect their focus on innovation. A great insight leads to strenuous research, which in turn forms the basis of a great product. There can be no compromise when it comes to patient health. At Pfizer, every product is designed to be the best in the market
- 11. Anti-Allergic • LC-OD M (Levocetrizine + Montelukast) • Levocetrizine Group (Levocetrizine) • LC-OD Plus (Levocetrizine + Montelukast +Dihydrochloride)
- 12. Anti-Diabetic • Amlogard-Met (Amlodipine + Metoprolol) • Bidiab (Metformin) • Immediab (Glimepiride) • Immediab-M (Metformin Glimepiride)
- 13. Multivitamins Becosule Capsules (Vit.B- Complex+ Vit.C)
- 14. Comparison
- 17. Market segmentation 9147.74; 28% 5826.39; 17% 4702.38; 14% 2749.39; 8% 2705.95; 8% 2514.09; 7% 1838.96; 5% 2409.11; 7% 1882.4; 6% Respiratory Central nervous system Anti-Virals Anti-Bacterials Metabolic Vaccines Oncology and emesis Cardiovascular Other 3538; 10% 5763; 15% 2633; 7% 1372; 4% 0; 0% 1669; 5% 2434; 7% 17958; 48% 1368; 4% Respiratory Central nervous system Urology Ophthalmology Vaccines Artrithis Oncology and emesis Cardiovascular Other
- 18. Corporate views and values Mission - to improve the quality of human life Purpose - dedicated to better health and greater access to healthcare. Research based pharmaceutical company Shape a flexible R&D organisation that can respond to the challenges and the opportunities - become the world's most valued company to patients, customers, colleagues, investors, business partners. - dedicated to better health and greater access to healthcare. Growth through innovation Research based pharmaceutical company
- 19. Customer - understanding and responding to their often changing needs. Personnel policy -GSK business employs over 100,000 people in 116 countries Over 15,000 people work in research teams to discover new medicines For employees, we create an environment that allows them to do their best work by being themselves Stakeholders - we must provide the right information in a timely and effective way. - deeply committed to meeting the needs of our customers, and we constantly focus on customer satisfaction - Pfizer employs 122,000 people in 60 countries and has sales in more than 150 countries. People are the cornerstone of Pfizer's success, we value our diversity as a source of strength, and we are proud of Pfizer's history of treating people with respect and dignity - We work with stakeholders to share knowledge, skills and goals on how to prevent or manage diseases, how to get medicine to the people who need it, and how to promote good health. Corporate views and values
- 20. Events (risks) • Product Recall & Litigations • Patent Expiration • BRIC Competition & Generics • Free Access & Price Dumping • Public opinion pressure
- 21. Markets (opportunities) • Cancer Treatment • Pandemic & Bioterrorism • Healthcare & Animal • Online Pharmacy • Developing World
- 22. Market Area
- 23. Market Area GlaxoSmithKline Pharmaceuticals Ltd. Parent Company GlaxoSmithKline Plc Category Pharmaceutical and Healthcare companies Sector Health Care Tagline/ Slogan Do more, feel better, live longer USP GlaxoSmithKline is the UK’s largest and world’s second largest pharmaceutical company
- 24. Overview (Glaxosmithkline) GSK Worldwide- • Focus • Strength • Trade • Rnd • Social responsibility programmes
- 25. SWOT Analysis for GSK Strength • Top 5 largest pharmaceutical companies • Innovation • Previous achievements • Strong R&d focus • Global presence • Employees strength Weakness • Safety of drugs affects • Patent expiry for a number of bulk-buster products Opportunity • Good network with competitor • Increasing awareness about healthcare needs • Global penetration • Increasing demand for quality healthcare solutions Threats • Risk of unsuccessful new Products • Regulatory environment • Economic meltdown
- 27. Pfizer Pfizer Parent Company Pfizer Ltd Category Pharmaceutical Sector Health care Tagline/ Slogan Doing things differently USP Pfizer Inc discovers, develops, manufactures, and markets leading prescription drugs
- 28. SWOT Analysis for Pfizer Strength • Largest pharmaceutical company spread over 50 countries • Excellent research and development (R&D) • 100,000 employees • Strong brand name and recall globally Weakness • Tough competition from other major pharmacy brands • Negative brand image due to involvement in largest healthcare fraud of marketing its drug illegally Opportunity • Strategic agreements with other pharmaceutical companies • Increasing awareness about healthcare needs • Global penetration through mergers and acquisitions • Increasing demand for quality healthcare solutions Threats • Risk of unsuccessful new Products • Regulatory environment is becoming more & more stringent • Economic slowdown in European markets
- 31. External analysis by Porter’s five forces model Organization Threat of New entrants Suppliers bargaining power Buyers Bargaining power Rivalry from competitors Threat of product substitute GlaxoSmith Kline Low Low Low High High Pfizer Low Low Low High High
- 32. Top 10 Exporting countries 1. Germany: (15.2%) 2. Switzerland: (10.5%) 3. Belgium: (9%) 4. France: (7.6%) 5. United States: (7.2%) 6. United Kingdom: (6.9%) 7. Italy: (6.5%) 8. Ireland: (5.8%) 9. Netherlands: (4.7%) 10. India: (3.1%)
- 34. Company Overview • Research based, global pharmaceutical company • Discovers, develops, manufactures and markets prescription drugs
- 35. The Problem With Pfizer's $17 Billion Buy Buying hospira hsp +%, the Lake Forest, Illinois-based hospital-focused drug maker, for $17 billion in cash and assumed debt to beef up its generic business
- 36. Pfizer accused of testing new drug without ethical approval • Pfizer did not obtain official approval before testing a new drug on children during a meningitis epidemic in Nigeria five years • Pfizer said that 15000 people died during the epidemic
- 37. Most ethical challenges in history • 1996: Eleven children died and many were disabled • 1998: The FDA approved Trovan for use in adults only • 1999: The European Union banned Trovan. • 2006: A Nigerian panel concluded that the Pfizer trial was an “illegal • 2010: Pfizer finally settled the suits for about $75 million
- 38. Pfizer’s Latest Twist on ‘Pay for Delay’ • The controversial practice, known as "pay for delay" • In 2008, the company settled patents litigations with Ranbaxy • Agreed to pay the $2.3 billion in fines
- 39. • Glaxosmithkline drug issue • Risked damaging the health of people around the world GlaxoSmithKline's bribes are evidence that Big Pharma isn't working
- 40. • Animal studies for an experimental therapy • Bribery of doctors in a position to prescribe its drugs. GlaxoSmithKline's China R&D audit found ethical
- 41. No doctors to promote its drugs Stop tying compensation for sales representatives GlaxoSmithKline to Quit Paying Doctors for Promotional Talks
Editor's Notes
- This slide represents the top ten pharmaceutical companies active on the drug market by its global sales according to data from 2005. As you can see two companies that we have chosen for our analysis are at the top of the list and currently playing very important role in pharmaceutical business.